S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma

Clinical Biochemistry
Riikka Harpio, Roland Einarsson

Abstract

Although histochemical staining of the S100 protein family has been used for many years in the diagnosis of malignant melanoma, recent studies suggest one of the proteins comprising the S100 family, S100B, has particular utility in many aspects of the clinical management of malignant melanoma. This protein has been shown to be of use in staging malignant melanoma, in establishing prognosis, in evaluating treatment success and in predicting relapse. S100B is an independent prognostic factor and pretreatment circulating S100B concentrations predict duration of survival in melanoma patients. Survival is significantly longer in melanoma patients with normal S100B levels compared to those with elevated levels. Circulating S100B levels very sensitively detect metastatic growth of malignant melanoma, particularly in stage IV disease where S100B is certainly superior to other laboratory parameters. S100B concentrations reflect tumor mass. Serum S100B levels predict efficacy of treatment. Decreasing S100B concentrations reflect response to therapy while increasing S100B concentrations indicate tumor progression. Circulating S100B has a role to play in the decision to switch treatment regimens.

References

Nov 1, 1988·Trends in Biochemical Sciences·D Kligman, D C Hilt
Sep 15, 1982·International Journal of Cancer. Journal International Du Cancer·A J CochranR B Gaynor
Jan 7, 1982·Nature·K StefanssonB G Arnason
May 1, 1981·European Journal of Biochemistry·T Isobe, T Okuyama
Jul 24, 1980·Nature·R GaynorH R Herschman
May 1, 1995·Progress in Neurobiology·G FanòP Calissano
Apr 1, 1995·Brain Research. Molecular Brain Research·S UedaE C Azmitia
Jan 1, 1995·Brain Research Bulletin·D B ZimmerW Song
Apr 1, 1996·Melanoma Research·E von SchoultzU Ringborg
Jan 1, 1997·Dermatology : International Journal for Clinical and Investigative Dermatology·G HenzeG Burg
Feb 12, 1998·The British Journal of Dermatology·H D AbrahaR A Sherwood
Sep 17, 1998·Journal of the American Academy of Dermatology·C L HuangR S Bart
Aug 22, 2000·The British Journal of Dermatology·L Brochez, J M Naeyaert
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·G GhanemUNKNOWN EORTC Melanoma Group
Mar 15, 2002·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rafael MolinaAntonio Manuel Ballesta

❮ Previous
Next ❯

Citations

Feb 14, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Felix M MottaghySven N Reske
Nov 11, 2009·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Simon J I SandlerP David Adelson
Oct 12, 2012·Amino Acids·Nadine TandlerJens Pietzsch
Sep 1, 2007·Clinical & Experimental Metastasis·Pia VihinenSeppo O Pyrhönen
Aug 11, 2005·Current Oncology Reports·Nicole Kounalakis, James S Goydos
May 25, 2007·Neurocritical Care·Stephen M BloomfieldJonathan Brisman
Aug 23, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Angel Díaz-LagaresAlvaro González
Jun 14, 2005·Current Opinion in Immunology·Ena WangFrancesco M Marincola
Jul 31, 2010·Cardiovascular Psychiatry and Neurology·Carlos Alberto GonçalvesMaria Cristina Guerra
Jun 24, 2010·Cancer Research·Anastasia Z KaleaBarry I Hudson
Oct 19, 2004·Journal of Translational Medicine·Ena WangFrancesco M Marincola
Dec 3, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ahmad A TarhiniJohn M Kirkwood
Mar 30, 2011·PloS One·Eva ThulinSara Linse
Feb 10, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Johann SteinerHans-Gert Bernstein
Mar 12, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Laurence Abeloos, Florence Lefranc
Feb 1, 2009·Biomarkers in Medicine·Monica NeaguIrina Margaritescu
Nov 3, 2010·Neurosurgical Focus·Aristotelis S FilippidisKostas N Fountas
Sep 6, 2012·International Journal of Molecular Sciences·Ting FuGuohui Li
Aug 24, 2013·Nuklearmedizin. Nuclear Medicine·H A WiederJ Nagarajah
Dec 22, 2012·Future Medicinal Chemistry·Kira G HartmanDavid J Weber
Jan 5, 2008·Neurological Research·Axel Petzold
Feb 1, 2012·Clinical & Developmental Immunology·Sapoznik SivanLotem Michal
Aug 24, 2007·Journal of Molecular Modeling·Artur GieldonRebecca Del Conte
Aug 18, 2006·The Journal of Head Trauma Rehabilitation·Rachel Pardes Berger
Mar 17, 2009·Journal of Cancer Research and Clinical Oncology·Julie CaronJérôme Solassol
Jun 30, 2006·Expert Opinion on Biological Therapy·Christian A PetrulioHoward L Kaufman
Jan 29, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Christoffer GebhardtJochen Utikal
Jan 31, 2012·Clinical Biochemistry·Gianfranco CervellinGiuseppe Lippi
May 6, 2008·Clinical Biochemistry·Carlos-Alberto GonçalvesPatrícia Nardin
Sep 11, 2014·Biochimica Et Biophysica Acta·Garrett DesmanJonathan H Zippin
Sep 27, 2015·Biochimica Et Biophysica Acta·Wiesława Leśniak, Agnieszka Graczyk-Jarzynka
Jul 25, 2009·The British Journal of Dermatology·L Jennings, G M Murphy
Mar 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K R WilhelmL A Morozova-Roche
Aug 30, 2008·International Journal of Cancer. Journal International Du Cancer·Simone MocellinDonato Nitti
Sep 12, 2008·Headache·Michael TeepkerKarsten Schepelmann
Jul 27, 2010·International Journal of Cancer. Journal International Du Cancer·Pekka RappuJyrki Heino
Mar 18, 2016·Cancer Immunology, Immunotherapy : CII·Jinbao ZongMichael R Shurin
Feb 11, 2015·International Journal of Experimental Pathology·Corina DanciuCristina Dehelean
Jun 15, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·I SalamaJ L Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.